Oleg Belyakov

Dr. Oleg Belyakov

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2020 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
VVVolodymyr Vinnikov
Volodymyr Vinnikov
PHPrakash Hande
Prakash Hande
RWRuth Wilkins
Ruth Wilkins
AWAndrzej Wojcik
Andrzej Wojcik
EZEduardo Zubizarreta
Eduardo Zubizarreta
OBOleg Belyakov
Oleg Belyakov
A search for effective methods for the assessment of patients’ individual response to radiation is one of the important tasks of clinical radiobiology. This review summarizes available data on the use of ex vivo cytogenetic markers, typically used for biodosimetry, for the prediction of individual clinical radiosensitivity (normal tissue toxicity, NTT) in cells of cancer patients undergoing therapeutic irradiation. In approximately 50% of the relevant reports, selected for the analysis in peer-reviewed international journals, the average ex vivo induced yield of these biodosimetric markers was higher in patients with severe reactions than in patients with a lower grade of NTT. Also, a significant correlation was sometimes found between the biodosimetric marker yield and the severity of acute or late NTT reactions at an individual level, but this observation was not unequivocally proven. A similar controversy of published results was found regarding the attempts to apply G2- and γH2AX foci assays for NTT prediction. A correlation between ex vivo cytogenetic biomarker yields and NTT occurred most frequently when chromosome aberrations (not micronuclei) were measured in lymphocytes (not fibroblasts) irradiated to relatively high doses (4–6 Gy, not 2 Gy) in patients with various grades of late (not early) radiotherapy (RT) morbidity. The limitations of existing approaches are discussed, and recommendations on the improvement of the ex vivo cytogenetic testing for NTT prediction are provided. However, the efficiency of these methods still needs to be validated in properly organized clinical trials involving large and verified patient cohorts.

1 July 2020 in Health Physics
Verified
Journal Article
Closed access
VVVolodymyr A. Vinnikov
Volodymyr A. Vinnikov
OBOleg Belyakov
Oleg Belyakov
The strategy toward personalized medicine in radiation oncology, nuclear medicine, and diagnostic and interventional radiology demands a specific set of assays for individualized estimation of radiation load for safety concerns and prognosis of normal tissue reactions caused by ionizing radiation. Apparently, it seems reasonable to use validated radiation dosimetric biomarkers for these purposes. However, a number of gaps in knowledge and methodological limitations still have to be resolved until dosimetric biomarkers will start to play a valuable role in clinical practice beyond radiation protection and radiation medicine. An extensive international multicenter research is necessary to improve the methodology of clinical applications of biodosimetry. That became a rationale for launching the IAEA Coordinated Research Project E35010 MEDBIODOSE: “Applications of Biological Dosimetry Methods in Radiation Oncology, Nuclear Medicine, and Diagnostic and Interventional Radiology.” At the 2nd Coordination Meeting on MEDBIODOSE (18–22 February 2019, Recife, Brazil), participants reported progress in the usage of biological dosimetry for genotoxicity assessment and/or individualization of radiotherapy treatment plans. Another avenue of research was the prognosis of normal tissue toxicity and cancer risk prediction using biomarkers’ yield measured in vivo or after ex vivo irradiation of patients’ cells. Other important areas are mechanisms of cytogenetic radiation response, validation of new radiation biomarkers, development of innovative techniques, automated and high-throughput assays for biodosimetry, and the overall improvement of biodosimetry service. An important aspect of clinical application of biodosimetry is standardization of techniques and unification of approaches to data interpretation. The new IAEA Biodosimetry/Radiobiology Laboratory, which is being established, will provide support for this activity. The declared lab’s mission includes, among other tasks, a harmonization of the biodosimetry applications with relevant international standards, guidelines on good laboratory practice, and the IAEA EPR-Biodosimetry manual.

31 December 2021 in Journal of Radiation Research
Verified
Journal Article
Open access
PDF file
WSWanwisa Sudprasert
Wanwisa Sudprasert
OBOleg Belyakov
Oleg Belyakov
STSatoshi Tashiro
Satoshi Tashiro
The International Atomic Energy Agency (IAEA) and Hiroshima International Council for Health Care of the Radiation-Exposed (HICARE) jointly organized two relevant workshops in Hiroshima, Japan, i.e. a Training Meeting ‘Biodosimetry in the 21st century’ (BIODOSE-21) on 10–14 June 2013 and a Workshop on ‘Biological and internal dosimetry: recent advance and clinical applications’ which took place between 17 and 21 February 2020. The main objective of the first meeting was to develop the ability of biodosimetry laboratories to use mature and novel techniques in biological dosimetry for the estimation of radiation doses received by individuals and populations. This meeting had a special focus on the Asia-Pacific region and was connected with the then on-going IAEA Coordinated Research Project (CRP) E35008 ‘Strengthening of “Biological dosimetry” in IAEA Member States: Improvement of current techniques and intensification of collaboration and networking among the different institutes’ (2012–17). The meeting was attended by 25 participants, which included 11 lecturers. The 14 trainees for this meeting came from India, Indonesia, Japan, Malaysia, Philippines, Republic of Korea, Singapore, Thailand and Vietnam. During the meeting 13 lectures by HICARE and IAEA invited lecturers were delivered besides eight research reports presented by the IAEA CRP E35008 network centers from the Asia-Pacific region. Two laboratory exercises were also undertaken, one each at Hiroshima University and the Radiation Effects Research Foundation (RERF). The second training workshop aimed to discuss with the participants the use of mature and novel techniques in biological and internal dosimetry for the estimation of radiation effects by accidental, environmental and medical exposures. The workshop was attended by 19 participants from Indonesia, Jordan, Oman, Philippines, Singapore, Syrian Arab Republic, Thailand, UAE, USA and Yemen. The main outcome of both meetings was a review of the state-of-the-art of biodosimetry and internal dosimetry and their future perspectives in medical management. This report highlights the learning outcome of two meetings for the benefit of all stake-holders in the field of biological and internal dosimetry.


24 February 2026 in Journal of Radiation Research
Verified
Journal Article
Open access
PDF file
WSWanwisa Sudprasert
Wanwisa Sudprasert
OBOleg Belyakov
Oleg Belyakov
STSatoshi Tashiro
Satoshi Tashiro
The HICARE/IAEA 2025 International Training Course on Biological and Internal Dosimetry, held at Hiroshima University from 10 to 14 February 2025, convened 20 participants from nine countries— Brazil, Indonesia, Japan, Korea, the Philippines, Singapore, Thailand, the United States, and Vietnam—and was jointly organized by the Hiroshima International Council for Health Care of the Radiation-Exposed (HICARE) and the International Atomic Energy Agency (IAEA). With guidance from 13 expert lecturers, the course aimed to enhance global capacity in radiation dose assessment and clinical application of biodosimetry. The program, led by Prof. Satoshi Tashiro (HICARE) and Dr. Oleg Belyakov (IAEA), included lectures on cytogenetic assays, molecular biomarkers, and internal dosimetry using biokinetic modeling and bioassay data. Key themes emphasized the integration of biodosimetry into clinical decision-making, emergency preparedness, and occupational health monitoring. Discussions highlighted the expanding role of biodosimetry in complementing internal dose assessments for patients undergoing diagnostic imaging procedures—such as CT scans and nuclear medicine—as well as for individuals affected by radiological accidents. These sessions underscored the need for harmonized protocols, reliable dose reconstruction methods, and cross-institutional networks to support accurate and timely biodosimetric evaluations in both clinical and emergency settings. The workshop not only had advanced technical competencies but also positioned biodosimetry as a critical tool in global radiological protection strategies. Strong participant engagement and interest in future events reflected the course’s impact on strengthening international cooperation and translating research into practice.